139 related articles for article (PubMed ID: 15501058)
1. Allosteric potentiators of the metabotropic glutamate receptor 2 (mGlu2). Part 2: 4-thiopyridyl acetophenones as non-tetrazole containing mGlu2 receptor potentiators.
Pinkerton AB; Cube RV; Hutchinson JH; James JK; Gardner MF; Schaffhauser H; Rowe BA; Daggett LP; Vernier JM
Bioorg Med Chem Lett; 2004 Dec; 14(23):5867-72. PubMed ID: 15501058
[TBL] [Abstract][Full Text] [Related]
2. Allosteric potentiators of the metabotropic glutamate receptor 2 (mGlu2). Part 1: Identification and synthesis of phenyl-tetrazolyl acetophenones.
Pinkerton AB; Cube RV; Hutchinson JH; Rowe BA; Schaffhauser H; Zhao X; Daggett LP; Vernier JM
Bioorg Med Chem Lett; 2004 Nov; 14(21):5329-32. PubMed ID: 15454221
[TBL] [Abstract][Full Text] [Related]
3. Allosteric potentiators of the metabotropic glutamate receptor 2 (mGlu2). Part 3: Identification and biological activity of indanone containing mGlu2 receptor potentiators.
Pinkerton AB; Cube RV; Hutchinson JH; James JK; Gardner MF; Rowe BA; Schaffhauser H; Rodriguez DE; Campbell UC; Daggett LP; Vernier JM
Bioorg Med Chem Lett; 2005 Mar; 15(6):1565-71. PubMed ID: 15745798
[TBL] [Abstract][Full Text] [Related]
4. Phenyl-tetrazolyl acetophenones: discovery of positive allosteric potentiatiors for the metabotropic glutamate 2 receptor.
Pinkerton AB; Vernier JM; Schaffhauser H; Rowe BA; Campbell UC; Rodriguez DE; Lorrain DS; Baccei CS; Daggett LP; Bristow LJ
J Med Chem; 2004 Aug; 47(18):4595-9. PubMed ID: 15317469
[TBL] [Abstract][Full Text] [Related]
5. Biphenyl-indanones: allosteric potentiators of the metabotropic glutamate subtype 2 receptor.
Bonnefous C; Vernier JM; Hutchinson JH; Gardner MF; Cramer M; James JK; Rowe BA; Daggett LP; Schaffhauser H; Kamenecka TM
Bioorg Med Chem Lett; 2005 Oct; 15(19):4354-8. PubMed ID: 16046122
[TBL] [Abstract][Full Text] [Related]
6. Benzazoles as allosteric potentiators of metabotropic glutamate receptor 2 (mGluR2): efficacy in an animal model for schizophrenia.
Govek SP; Bonnefous C; Hutchinson JH; Kamenecka T; McQuiston J; Pracitto R; Zhao LX; Gardner MF; James JK; Daggett LP; Rowe BA; Schaffhauser H; Bristow LJ; Campbell UC; Rodriguez DE; Vernier JM
Bioorg Med Chem Lett; 2005 Sep; 15(18):4068-72. PubMed ID: 16005222
[TBL] [Abstract][Full Text] [Related]
7. Discovery of allosteric potentiators for the metabotropic glutamate 2 receptor: synthesis and subtype selectivity of N-(4-(2-methoxyphenoxy)phenyl)-N-(2,2,2- trifluoroethylsulfonyl)pyrid-3-ylmethylamine.
Johnson MP; Baez M; Jagdmann GE; Britton TC; Large TH; Callagaro DO; Tizzano JP; Monn JA; Schoepp DD
J Med Chem; 2003 Jul; 46(15):3189-92. PubMed ID: 12852748
[TBL] [Abstract][Full Text] [Related]
8. SAR study of a subtype selective allosteric potentiator of metabotropic glutamate 2 receptor, N-(4-phenoxyphenyl)-N-(3-pyridinylmethyl)ethanesulfonamide.
Barda DA; Wang ZQ; Britton TC; Henry SS; Jagdmann GE; Coleman DS; Johnson MP; Andis SL; Schoepp DD
Bioorg Med Chem Lett; 2004 Jun; 14(12):3099-102. PubMed ID: 15149652
[TBL] [Abstract][Full Text] [Related]
9. Allosteric modulators of metabotropic glutamate receptors: lessons learnt from mGlu1, mGlu2 and mGlu5 potentiators and antagonists.
Johnson MP; Nisenbaum ES; Large TH; Emkey R; Baez M; Kingston AE
Biochem Soc Trans; 2004 Nov; 32(Pt 5):881-7. PubMed ID: 15494040
[TBL] [Abstract][Full Text] [Related]
10. Scaffold hopping from pyridones to imidazo[1,2-a]pyridines. New positive allosteric modulators of metabotropic glutamate 2 receptor.
Tresadern G; Cid JM; Macdonald GJ; Vega JA; de Lucas AI; García A; Matesanz E; Linares ML; Oehlrich D; Lavreysen H; Biesmans I; Trabanco AA
Bioorg Med Chem Lett; 2010 Jan; 20(1):175-9. PubMed ID: 19932615
[TBL] [Abstract][Full Text] [Related]
11. Discovery of a potent and brain penetrant mGluR5 positive allosteric modulator.
Ritzén A; Sindet R; Hentzer M; Svendsen N; Brodbeck RM; Bundgaard C
Bioorg Med Chem Lett; 2009 Jun; 19(12):3275-8. PubMed ID: 19443216
[TBL] [Abstract][Full Text] [Related]
12. 3-[Substituted]-5-(5-pyridin-2-yl-2H-tetrazol-2-yl)benzonitriles: identification of highly potent and selective metabotropic glutamate subtype 5 receptor antagonists.
Tehrani LR; Smith ND; Huang D; Poon SF; Roppe JR; Seiders TJ; Chapman DF; Chung J; Cramer M; Cosford ND
Bioorg Med Chem Lett; 2005 Nov; 15(22):5061-4. PubMed ID: 16183275
[TBL] [Abstract][Full Text] [Related]
13. New positive allosteric modulators of the metabotropic glutamate receptor 2 (mGluR2): identification and synthesis of N-propyl-8-chloro-6-substituted isoquinolones.
Trabanco AA; Duvey G; Cid JM; Macdonald GJ; Cluzeau P; Nhem V; Furnari R; Behaj N; Poulain G; Finn T; Lavreysen H; Poli S; Raux A; Thollon Y; Poirier N; D'Addona D; Andrés JI; Lutjens R; Le Poul E; Imogai H; Rocher JP
Bioorg Med Chem Lett; 2011 Feb; 21(3):971-6. PubMed ID: 21232953
[TBL] [Abstract][Full Text] [Related]
14. Discovery of positive allosteric modulators for the metabotropic glutamate receptor subtype 5 from a series of N-(1,3-diphenyl-1H- pyrazol-5-yl)benzamides that potentiate receptor function in vivo.
Lindsley CW; Wisnoski DD; Leister WH; O'brien JA; Lemaire W; Williams DL; Burno M; Sur C; Kinney GG; Pettibone DJ; Tiller PR; Smith S; Duggan ME; Hartman GD; Conn PJ; Huff JR
J Med Chem; 2004 Nov; 47(24):5825-8. PubMed ID: 15537338
[TBL] [Abstract][Full Text] [Related]
15. Progress in the developement of positive allosteric modulators of the metabotropic glutamate receptor 2.
Trabanco AA; Cid JM; Lavreysen H; Macdonald GJ; Tresadern G
Curr Med Chem; 2011; 18(1):47-68. PubMed ID: 21110815
[TBL] [Abstract][Full Text] [Related]
16. Discovery of 5-aryl-1,3-dihydro-2H-imidazo[4,5-b]pyridin-2-ones as positive allosteric modulators of metabotropic glutamate subtype-2 (mGlu2) receptors with efficacy in a preclinical model of psychosis.
Layton ME; Reif AJ; Hartingh TJ; Rodzinak K; Dudkin V; Wang C; Arrington K; Kelly MJ; Garbaccio RM; O'Brien JA; Magliaro BC; Uslaner JM; Huszar SL; Fillgrove KL; Tang C; Kuo Y; Jacobson MA
Bioorg Med Chem Lett; 2016 Feb; 26(4):1260-4. PubMed ID: 26810316
[TBL] [Abstract][Full Text] [Related]
17. Imidazo[1,2-a]pyridines: orally active positive allosteric modulators of the metabotropic glutamate 2 receptor.
Trabanco AA; Tresadern G; Macdonald GJ; Vega JA; de Lucas AI; Matesanz E; García A; Linares ML; Alonso de Diego SA; Alonso JM; Oehlrich D; Ahnaou A; Drinkenburg W; Mackie C; Andrés JI; Lavreysen H; Cid JM
J Med Chem; 2012 Mar; 55(6):2688-701. PubMed ID: 22352782
[TBL] [Abstract][Full Text] [Related]
18. Discovery of dual positive allosteric modulators (PAMs) of the metabotropic glutamate 2 receptor and CysLT1 antagonists for treating migraine headache.
Blanco MJ; Benesh DR; Knobelsdorf JA; Khilevich A; Cortez GS; Mokube F; Aicher TD; Groendyke TM; Marmsater FP; Tang TP; Johnson KW; Clemens-Smith A; Muhlhauser MA; Swanson S; Catlow J; Emkey R; Johnson MP; Schkeryantz JM
Bioorg Med Chem Lett; 2017 Jan; 27(2):323-328. PubMed ID: 27908761
[TBL] [Abstract][Full Text] [Related]
19. Pyrimidine methyl anilines: selective potentiators for the metabotropic glutamate 2 receptor.
Hu E; Chua PC; Tehrani L; Nagasawa JY; Pinkerton AB; Rowe BA; Vernier JM; Hutchinson JH; Cosford ND
Bioorg Med Chem Lett; 2004 Oct; 14(20):5071-4. PubMed ID: 15380201
[TBL] [Abstract][Full Text] [Related]
20. Positive allosteric modulators of the metabotropic glutamate receptor 2 for the treatment of schizophrenia.
Fraley ME
Expert Opin Ther Pat; 2009 Sep; 19(9):1259-75. PubMed ID: 19552508
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
